All Posts

Join the MBI and 10x Genomics to discuss new additions to the MBI Molecular Core - the Chromium single-cell platform and Visium spatial transcriptomics platform.

In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, MBI researchers have found.

In The Conversation, Dr. Carol Mathews discusses the trend of rising ADHD diagnoses and what this means.

Dr. Zahra Hasanpour-Segherlou received a grant for her investigation into a new therapeutic strategy to protect the brain after subarachnoid hemorrhage.

The MBI community gathered on Fridays in September for a new breakfast seminar series, “Brains & Bagels,” which features in-depth discussions on pressing topics in brain research.

Under new $2.6 million NIH grant MBI researchers will investigate why some patients respond to dendritic cell therapy and some do not.

MBI researchers found that optimism, good sleep, social support and other healthy habits were associated with slower brain aging, even in people living with chronic pain.

Catch up on some of the latest neuroscience and neuromedicine research news around the MBI.

In the San Antonio Express-News, Dr. Catherine Price discusses the importance of assessing cognition before surgery.